Forget Fortescue and buy these ASX shares

The team at Morgans has been busy updating its recommendations this week following a flurry of results releases.

Let’s now take a look at two that it remains positive on and one that it thinks investors should be avoiding. Here’s what it is recommending:

Fortescue…